Optimizing Biologically Targeted Clinical Trials for Neurofibromatosis
Expert Opinion on Investigational Drugs - United Kingdom
doi 10.1517/13543784.2013.772979
Full Text
Open PDFAbstract
Available in full text
Date
February 21, 2013
Authors
Publisher
Informa Healthcare